- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4172 - Imidazole-alkanecarboxylic acids, e.g. histidine
Patent holdings for IPC class A61K 31/4172
Total number of patents in this class: 612
10-year publication summary
40
|
60
|
46
|
45
|
51
|
55
|
59
|
82
|
78
|
28
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Ajinomoto Co., Inc. | 2337 |
32 |
Suntory Holdings Limited | 1846 |
21 |
Exela Pharma Sciences, LLC | 18 |
16 |
Société des Produits Nestlé S.A. | 9672 |
14 |
Antecip Bioventures II LLC | 300 |
13 |
Axcella (assignment for The Benefit of Creditors), LLC | 41 |
12 |
Nanjing Nutrabuilding Bio-Tech Co., Ltd. | 163 |
11 |
APR Applied Pharma Research SA | 69 |
10 |
Professional Dietetics S.p.A. | 82 |
10 |
N.V. Nutricia | 1022 |
9 |
Regeneron Pharmaceuticals, Inc. | 3650 |
9 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
8 |
Dyve Biosciences, Inc. | 31 |
8 |
Axcella Health Inc. | 33 |
7 |
Meiji Dairies Corporation | 102 |
7 |
Hebei Kexing Pharmaceutical Co., Ltd | 12 |
7 |
Takeda Pharmaceutical Company Limited | 2961 |
6 |
International Dehydrated Foods, Inc. | 60 |
6 |
University of Florida Research Foundation, Inc. | 3883 |
5 |
MannKind Corporation | 531 |
5 |
Other owners | 396 |